MORE►
Bob Sifferman
Applications for the Arlington small business growth program will be accepted from June 4 to June 28 with the cohort kicking off the week of July 22, 2024. [Photo: Arlington EDC]
Arlington EDC and SCORE Launch Program to Propel Small Business Growth. Here’s Your Path to Participation
by Dallas Innovates | Staff Report | Jun 3, 2024
Up to 18 Arlington business owners will be selected for a new Small Business Development Cohort, with the application window opening on June 4 and closing on June 28, 2024.
Related Articles
Last Call for AI 75 2025: Who’s Shaping AI in Dallas-Fort Worth?
USPTO Releases Expansion of IP Identifier Tool, New Startup Certification Training Course
Last Call!: Submit Your Nominations for The Innovation Awards 2025
Nominate Now: Venture Dallas Kicks Off 2024 Startup Awards Nominations
Apply Now: Dallas-Based Consulting Firm Partners With Dallas College and UPS Foundation to Offer Accelerator to DFW Small Businesses
MORE►
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
Trending
North Texas is a big place, with plenty to do, see, hear, and watch. We scour the internet every week to find events and activities for you. As always, things may change at any time, so be sure to check the official website or registration page for the latest details....
More than two years since generative AI exploded onto the radar of business leaders, the technology continues to mature. In 2025, AI is capable of driving real results across the enterprise....
Veteran banking executive Eric Teal has been named chief investment officer of Dallas-based Comerica Inc. He will be responsible for providing enterprise-wide leadership of investment strategy, portfolio construction, and enhancement of the Comerica Investment Management brand, Comerica said....
Plano-based payment technology provider Fortis has appointed two industry veterans to its executive leadership team: Brad Bialas as chief commercial officer and Kimling Lam as chief marketing officer.
Fortis said the appointments position Fortis for its next phase of aggressive growth across the software and ERP ecosystem....
Marshelle Smith Warren, MD, has been appointed chief medical officer of Dallas-based Secretome Therapeutics, a clinical-stage biotechnology company that is pioneering therapies derived from neonatal cardiac progenitor cells (nCPCs).
The company said Warren is a highly experienced pharmaceutical executive with more than two decades of leadership in clinical development, translational medicine, and regulatory strategy across multiple therapeutic areas, including cell therapy, immunology, cardiovascular, and rare diseases....
